DAIC

MARCH 6, 2024

Food and Drug Administration’s ( FDA ) Breakthrough Device Designation for their ECGvision-TTR Technology for early detection of ATTR-Cardiomyopathy. Food and Drug Administration’s (FDA) Breakthrough Devices Program , which provides patients with timely access to innovative medical devices.

Technology 105

Technology Cardiomyopathy Quality of Life Innovation 105

Frontiers in Cardiovascular Medicine

JUNE 28, 2024

Septic cardiomyopathy, a life-threatening complication of sepsis, can cause acute heart failure and carry a high mortality risk. Fortunately, engineered exosomes, created through bioengineering technology, may represent a potential new treatment method. Current treatments have limitations.

Cardiomyopathy 52

Cardiomyopathy Article Technology Cardiac Function 52

DAIC

APRIL 3, 2024

This leap in early detection marks both a significant medical innovation and a new era in the detection of cardiovascular disease. Importantly, since a stethoscope is small and portable, this technology can be used in urban and remote locations, and hopefully help address care in underserved areas.” For the first time, U.S. In the U.S.,

Heart Failure 111

Heart Failure Cardiomyopathy AFIB Hospital 111

DAIC

MARCH 8, 2024

million Department of Defense grant awarded to the Georgia Institute of Technology (Georgia Tech), Yaxin Wang, PhD (seated left), O.H. Through a new four-year, $7.8 The research is funded by a four-year, $7.8 The Texas Heart Institute will receive approximately $2.94 million from the award to fund its role in the research effort.

Blood Clot 98

Blood Clot Heart Failure Quality of Life Innovation 98

DAIC

FEBRUARY 18, 2025

11, 2025 UltraSight, a company committed to enhancing the efficiency and productivity of cardiac ultrasound,recentlyannounced support from Bristol Myers Squibb (BMS) for a study that aims to improve access to echocardiographic assessments for patients with obstructive hypertrophic cardiomyopathy (oHCM). tim.hodson Tue, 02/18/2025 - 16:17 Feb.

Ultrasound 52

Ultrasound Echocardiogram Innovation Cardiomyopathy 52

Wellnest

JUNE 19, 2023

By harnessing the power of the latest technology, healthcare providers can enhance diagnostics, treatment planning, and patient care. The latest technology utilizes the existing data of an Artificial Neural network (ANN). The deep learning algorithm helps segment the left ventricle predicting cardiomyopathy and ejection fraction.

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52

Cardiology Update

JUNE 24, 2024

Integration and Advancements In the second stage, spanning the 1980s to 2010, significant progress was made in using magnetic resonance technology to capture various cardiovascular images. This comprehensive approach allows for precise differentiation between various cardiomyopathies, myocarditis, and myocardial infarction.

Myocardial Infarction 52

Myocardial Infarction Anatomy Cardiovascular Imaging Research 52